Anthem Blue Cross Blue Shield halts anesthesia payment policy after backlash
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
Our newest portfolio stock backed off its recent 52-week high — so we're buying more
UnitedHealthcare CEO Brian Thompson fatally shot in New York
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
